Multidimensional Impact of Polypharmacy on Cognitive Function, Depression, Functionality, and Quality of Life in Older Adults: A Cross-Sectional Study
İzmir Katip Çelebi Üniversitesi Sağlık Bilimleri Fakültesi Dergisi · 31.05.2026 · 11 (2) · 245-251
DOI: 10.61399/ikcusbfd.1704906 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift İzmir Katip Çelebi Üniversitesi Sağlık Bilimleri Fakültesi Dergisi, online erschienen am 31.05.2026. Verfasst von Emre Dansuk und 1 weiteren Autor:innen. Die Arbeit nennt 26 Literaturangaben.
Themen: Medikationssicherheit, Gerontologische Pflege, Depression
Abstract (Originalsprache)
Objective
This study aimed to evaluate the effects of polypharmacy on cognitive function, depression levels, activities of daily living, and qualityof life in individuals aged 65 years and older.Material and Methods: This cross-sectional study included a total of 164 older adults (mean age: 73 years) who presented to the geriatricoutpatient clinic of a university hospital. Participants were divided into two groups based on the number of medications used: the polypharmacygroup (≥5 medications) and the non-polypharmacy group (0–4 medications). Cognitive function was assessed using the Mini-Mental StateExamination (MMSE), depression with the Geriatric Depression Scale (GDS), activities of daily living with the Barthel Index (BI), and quality of lifewith the WHOQOL-OLD scale.
Results
No statistically significant differences were found between the groups in terms of cognitive function (p = 0.910), depression levels (p =0.585), or activities of daily living (p = 0.656). However, the non-polypharmacy group showed significantly higher scores in the WHOQOL-OLDtotal score (p = 0.013), as well as in the subdomains of social participation (p = 0.038), death and dying (p = 0.046), and intimacy (p = 0.046).
Conclusion
Polypharmacy may negatively affect quality of life in older adults; however, its cognitive and functional effects may vary dependingon sample characteristics. These findings highlight the importance of conducting comprehensive and individualized assessments of polypharmacyin geriatric populations.
Zitieren
APA
Dansuk, E., & Menek, B. (2026). Multidimensional Impact of Polypharmacy on Cognitive Function, Depression, Functionality, and Quality of Life in Older Adults: A Cross-Sectional Study. İzmir Katip Çelebi Üniversitesi Sağlık Bilimleri Fakültesi Dergisi, 11(2), 245-251. https://doi.org/10.61399/ikcusbfd.1704906
Vancouver
Dansuk E, Menek B. Multidimensional Impact of Polypharmacy on Cognitive Function, Depression, Functionality, and Quality of Life in Older Adults: A Cross-Sectional Study. İzmir Katip Çelebi Üniversitesi Sağlık Bilimleri Fakültesi Dergisi. 2026;11(2):245-251. doi:10.61399/ikcusbfd.1704906
BibTeX
@article{Dansuk2026,
author = {Dansuk, Emre and Menek, Burak},
title = {Multidimensional Impact of Polypharmacy on Cognitive Function, Depression, Functionality, and Quality of Life in Older Adults: A Cross-Sectional Study},
journal = {İzmir Katip Çelebi Üniversitesi Sağlık Bilimleri Fakültesi Dergisi},
year = {2026},
volume = {11},
number = {2},
pages = {245--251},
doi = {10.61399/ikcusbfd.1704906}
}
EUVIMED